Converge Bio x Tech | Biocom & Bits in Bio
REGISTRATION LINK: https://www.biocom.org/event/Converge-Meet-Up-Seattle-2025/
FREE registration for Bits in Bio Members - use code BITSINBIOGUEST (case sensitive)
The convergence of technology and life sciences presents unparalleled opportunities for collaboration, discovery, and innovation. Converge by Biocom is where the brightest minds in biotech, pharma, medtech, and technology come together to explore transformative ideas, build relationships, and ignite partnerships that can change the world.
Our inaugural Seattle Converge Meet-Up will spotlight collaborations, partnerships and the tools transforming innovation, with a special focus on the game-changing intersections between biotech and big tech as well as the regional and nation-wide collaborations shaping the future of drug discovery, clinical trials, patient care and beyond.
Event Agenda
5:30 p.m. to 6:00 p.m. | Registration & Networking
6:00 p.m. to 7:15 p.m. | Lightning Talks + Venture Panel
Emcee: Jagveer Singh, Senior Software Engineer, Arzeda; Chapter Lead, Bits in Bio Seattle
Advancements in Drug Development – Robert Pierce, M.D., Chief Medical Officer, Yatiri Bio
Lilly TuneLab AI/ML Drug Discovery Platform- Vanessa Braunstein, Sr. Director, Lilly TuneLab AI Drug Discovery Platform, Eli Lilly and Company
AI/ML in Genome Engineering and Genetic Medicine- Amicia Elliott, Ph.D., Vice President, Product, Form Bio
Venture Panel -
(Moderator) Aaron Coe, Managing Director, Innovation Portfolio, Allen Institute
Kristina Kitko, Head of AI Investing Lilly Ventures
Chris Picardo, Partner, Madrona Venture Group
Zainab Bakrin, Associate, Gates Strategic Investment Fund
7:15 p.m. to 8:00 p.m. | Networking Reception